The research team built a stem cell factory with a specific culture program to achieve high-throughput production of human mitochondria, providing a new solution for the treatment of osteoarthritis.

The research team conducted a comprehensive investigation of umbilical cord mesenchymal stromal cell (UC-MSC) -derived exosomes (SEVs) with the help of a variety of in vitro and in vivo experiments.

The research article provides a breakthrough theoretical basis to completely solve this problem that has plagued the development of the industry for a long time.

The study presents preclinical data on the safety and efficacy of autologous cell therapy based on human induced pluripotent stem cells (hiPSC) for Parkinson's disease, on which a clinical trial will be conducted in eight patients with Parkinson's disease.

This review explores the use of iPSCs in the treatment and modeling of skeletal muscle diseases.

Using human induced pluripotent stem cell (iPSC) -derived liver organoids (iHOs), this study successfully obtained powerful iHO-Heps hepatocytes by optimizing culture conditions and developing two-dimensional (2D) culture protocols.

In recent years, mesenchymal stromal cells (MSCs) have become a hot topic in RA treatment research due to their unique immunoregulation and tissue repair capabilities.

Studies have found that iMSCs are not as effective as BM-MSCs in promoting angiogenesis, which are more effective in stimulating endothelial cells to form interconnected vascular structures.